Zomedica Corp. [AMEX: ZOM] slipped around -0.01 points on Tuesday, while shares priced at $0.61 at the close of the session, down -2.82%. The company report on July 30, 2021 that Zomedica Announces 2021 Annual Meeting Results.
Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for companion animals, announced the voting results of its 2021 Annual Virtual-Only Meeting of Shareholders (the “Meeting”) held on July 30, 2021.
At the Meeting, the Company’s shareholders approved the items of business as follows:.
Zomedica Corp. stock is now 163.10% up from its year-to-date (YTD) trading value. ZOM Stock saw the intraday high of $0.62 and lowest of $0.59 per share. The company’s 52-week high price is 2.91, which means current price is +146.63% above from all time high which was touched on 02/08/21.
Compared to the average trading volume of 29.56M shares, ZOM reached a trading volume of 14225996 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Zomedica Corp. [ZOM]?
The Average True Range (ATR) for Zomedica Corp. is set at 0.04, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 42142.97. The Price to Book ratio for the last quarter was 1.96, with the Price to Cash per share for the same quarter was set at 0.28.
How has ZOM stock performed recently?
Zomedica Corp. [ZOM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.00. With this latest performance, ZOM shares dropped by -22.22% in over the last four-week period, additionally sinking by -43.82% over the last 6 months – not to mention a rise of 281.57% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 36.16, with the RSI for the last a single of trading hit 37.00, and the three-weeks RSI is set at 37.30 for Zomedica Corp. [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.7794, while it was recorded at 0.6175 for the last single week of trading, and 0.9040 for the last 200 days.
Zomedica Corp. [ZOM]: Deeper insight into the fundamentals
Return on Total Capital for ZOM is now -50.05, given the latest momentum, and Return on Invested Capital for the company is -51.08. Return on Equity for this stock declined to -51.94, with Return on Assets sitting at -48.09. When it comes to the capital structure of this company, Zomedica Corp. [ZOM] has a Total Debt to Total Equity ratio set at 2.96. Additionally, ZOM Total Debt to Total Capital is recorded at 2.88, with Total Debt to Total Assets ending up at 2.82. Long-Term Debt to Equity for the company is recorded at 2.13, with the Long-Term Debt to Total Capital now at 1.68.
Zomedica Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 141.80 and a Current Ratio set at 141.90.
Insider trade positions for Zomedica Corp. [ZOM]
There are presently around $62 million, or 12.60% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 40,776,197, which is approximately 110.834% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 17,170,960 shares of the stock with an approximate value of $10.42 million in ZOM stocks shares; and CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC., currently with $7.44 million in ZOM stock with ownership of nearly 0.002% of the company’s market capitalization.
Positions in Zomedica Corp. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 69 institutional holders increased their position in Zomedica Corp. [AMEX:ZOM] by around 55,638,447 shares. Additionally, 20 investors decreased positions by around 1,968,660 shares, while 22 investors held positions by with 44,524,703 shares. The mentioned changes placed institutional holdings at 102,131,810 shares, according to the latest SEC report filing. ZOM stock had 52 new institutional investments in for a total of 17,545,731 shares, while 12 institutional investors sold positions of 1,661,514 shares during the same period.